Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

Patrocinado

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

Postado

147

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

Faça Login para curtir, compartilhar e comentar!

‘100 per cent’: Musk says his America Party will expose Epstein files; deepens rift with Trump

Elon Musk has declared that exposing the Jeffrey Epstein files will be a "top priority" for his...

Por 0 8

FIFA CWC: Joao Pedro brace sends Chelsea into final, beat Fluminense 2-0

Joao Pedro, Chelsea's recent £60 million acquisition, showcased his prowess with a stunning...

Por 0 8

'He panicked, he blundered': Gayle slams Mulder for not chasing Lara’s record

Wiaan Mulder's record-breaking 367* against Zimbabwe was overshadowed by his decision to declare,...

Por 0 8

Floods and landslides block 10 major highways across Nepal

KATHMANDU: Continuous rainfall has triggered floods and landslides across the country,...

Por 0 13

‘May have implications on India's stability’: CDS warns of China-Pakistan-Bangladesh axis; watch

Por 0 11